🟢 STAAR Surgical is trading 5% up today after reporting third-quarter results

STAAR Surgical is trading 5.48% up at $27.58 after reporting third-quarter results.

• Revenue was $83.4 million; excluding an unusual prior-year China revenue item, sales grew 21%. The reported decline reflects a difficult comparison with $25.9 million of deferred China sales recognized in 2025.
• The stock’s move extends its 7.95% gain on November 4 after the results. The company highlighted strong EMEA growth and reaffirmed confidence in full-year GAAP net income.
• The board authorized a $50 million share repurchase program.